These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14518171)

  • 1. [Schizophrenia, neurodevelopment and glycogen synthase kinase-3].
    Nadri C; Kozlovsky N; Agam G
    Harefuah; 2003 Sep; 142(8-9):636-42, 644. PubMed ID: 14518171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-3 and the neurodevelopmental hypothesis of schizophrenia.
    Kozlovsky N; Belmaker RH; Agam G
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):13-25. PubMed ID: 11788236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult.
    Kozlovsky N; Nadri C; Agam G
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):1-11. PubMed ID: 15572268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia as a GSK-3 dysregulation disorder.
    Lovestone S; Killick R; Di Forti M; Murray R
    Trends Neurosci; 2007 Apr; 30(4):142-9. PubMed ID: 17324475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between the Wnt signaling and the psychiatric diseases].
    Ferrero A; Cereseto M; Sifonios L
    Vertex; 2006; 17(67):165-71. PubMed ID: 16847474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glycogen synthase kinase-3beta in schizophrenia.
    Koros E; Dorner-Ciossek C
    Drug News Perspect; 2007 Sep; 20(7):437-45. PubMed ID: 17992266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.
    Haraguchi K; Ohsugi M; Abe Y; Semba K; Akiyama T; Yamamoto T
    Oncogene; 2008 Jan; 27(3):274-84. PubMed ID: 17621269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Akt-GSK-3beta signaling and synaptic strength in phencyclidine-induced neurodegeneration.
    Lei G; Xia Y; Johnson KM
    Neuropsychopharmacology; 2008 May; 33(6):1343-53. PubMed ID: 17637606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
    Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
    Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain.
    Swatton JE; Sellers LA; Faull RL; Holland A; Iritani S; Bahn S
    Eur J Neurosci; 2004 May; 19(10):2711-9. PubMed ID: 15147305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
    Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
    Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
    Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
    J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
    Kaga S; Zhan L; Altaf E; Maulik N
    J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3: The missing link to aberrant circuit function in disorders of cognitive dysfunction?
    Manduca JD; Thériault RK; Perreault ML
    Pharmacol Res; 2020 Jul; 157():104819. PubMed ID: 32305493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.
    Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC
    FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
    Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
    Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK-3 parameters in lymphocytes of schizophrenic patients.
    Nadri C; Kozlovsky N; Agam G; Bersudsky Y
    Psychiatry Res; 2002 Sep; 112(1):51-7. PubMed ID: 12379450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.